William Blair & Company
PBYI icon

William Blair & Company’s Puma Biotechnology PBYI Stock Holding History

William Blair & Company’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,440
Closed -$251K – 1736
2019
Q2 		$251K Hold
3,440
– – ﹤0.01% 1219
2019
Q1 		$251K Buy
3,440
+440
+15% +$13.4K ﹤0.01% 1217
2018
Q4 		$219K Buy
+3,000
New +$90K ﹤0.01% 1205
2018
Q2 		– Sell
-3,000
Closed -$204K – 1617
2018
Q1 		$204K Hold
3,000
– – ﹤0.01% 1200
2017
Q4 		$297K Hold
3,000
– – ﹤0.01% 1134
2017
Q3 		$359K Hold
3,000
– – ﹤0.01% 1050
2017
Q2 		$262K Buy
+3,000
New +$168K ﹤0.01% 1245

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

William Blair & Company's PBYI Position: Q3 2019 in Review

William Blair & Company sold out of Puma Biotechnology (PBYI) in Q3 2019, closing a stake of 3,440 shares — an estimated $251K sold.

William Blair & Company first reported a position in PBYI in Q2 2017 and held it in 7 quarters. The position peaked at $359K in Q3 2017. 144 funds tracked by Wall St. Rank hold PBYI as of Q3 2019.

  • William Blair & Company reported no remaining Puma Biotechnology position as of Q3 2019 after selling out during the quarter.
  • William Blair & Company sold 3,440 Puma Biotechnology shares in Q3 2019, an estimated $251K.
  • William Blair & Company first reported a position in Puma Biotechnology in Q2 2017 and held it in 7 quarters.
  • William Blair & Company's Puma Biotechnology position peaked at $359K in Q3 2017.
  • 144 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2019.

Based on William Blair & Company's 13F filing for Q3 2019, filed 12 Nov 2019.